soft-tissue-sarcoma

Documents about soft-tissue-sarcoma

• Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization#1009993ClinicalTrials.gov
• De-identified clinical dataset supporting "Breast metastasis from retroperitoneal dedifferentiated liposarcoma: a case report"#377644Figshare
• Retreatment With Intratumoral Diffusing Alpha Radiation Emitters#872768ClinicalTrials.gov
• Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors#245375ClinicalTrials.gov
• A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers#825040ClinicalTrials.gov
• DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML#853908ClinicalTrials.gov
• This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)#918216ClinicalTrials.gov
• A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma#830255ClinicalTrials.gov
• Pharmacokinetic Study of Doxorubicin in Children With Cancer#860728ClinicalTrials.gov
• Biomarkers of Resiliency In Childhood Cancer Surgery#835320ClinicalTrials.gov
• Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)#900103ClinicalTrials.gov
• A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors#912007ClinicalTrials.gov
• PP-Gemcitabine & External Beam Radiation-Sarcomas#892242ClinicalTrials.gov
• Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment#894099ClinicalTrials.gov
• Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma#1031441ClinicalTrials.gov
• Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma#208429ClinicalTrials.gov
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI#127577ClinicalTrials.gov
• Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France.#281194NCBI PubMed Central
• Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas#843199ClinicalTrials.gov
• A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue#353272ClinicalTrials.gov
• Radiolabeled MAB Therapy in Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer#855357ClinicalTrials.gov
• Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours#865404ClinicalTrials.gov
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors#1045404ClinicalTrials.gov
• Vinorelbine in Treating Children With Recurrent or Refractory Cancers#864583ClinicalTrials.gov
• Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)#980926ClinicalTrials.gov
• Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures#890347ClinicalTrials.gov
• Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy#898559ClinicalTrials.gov
• High-Dose Methotrexate in Treating Young Patients With Solid Tumors#994714ClinicalTrials.gov
• A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors#1031223ClinicalTrials.gov
• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies#895092ClinicalTrials.gov
• Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research#979840ClinicalTrials.gov
• A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma#854383ClinicalTrials.gov
• Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers#801878ClinicalTrials.gov
• RECURRENT MALIGNANT PERIPHERAL NERVE SHEATH TUMOR OF THE LEFT FEMUR POST MULTIMODAL THERAPY IN 61 YEARS OLD MALE: A CASE REPORT#194596Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal)
• SMMART Adaptive Clinical Treatment (ACT) Trial#805987ClinicalTrials.gov
• Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients#826611ClinicalTrials.gov
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma#902352ClinicalTrials.gov
• Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides#874538ClinicalTrials.gov
• Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS#1030131ClinicalTrials.gov
• NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)#1030665ClinicalTrials.gov
• A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors#911909ClinicalTrials.gov
• A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)#162475ClinicalTrials.gov
• FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)#882957ClinicalTrials.gov